Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$405M |
| 2 |
Enbridge
ENB
|
+$200M |
| 3 |
Abbott
ABT
|
+$132M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$109M |
| 5 |
Incyte
INCY
|
+$108M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$2.73B |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$466M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$271M |
| 4 |
STJ
St Jude Medical
STJ
|
+$218M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.01% |
| 2 | Technology | 13.95% |
| 3 | Healthcare | 12.34% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSGS
1651
DELISTED
CSG Systems International
CSGS
| $19M | 0.01% |
501,845
+1,923
| +0.4% | +$81.5K |
|
1652
Myriad Genetics
MYGN
$311M
| $18.9M | 0.01% |
986,312
+149
| +0% | +$2.64K |
|
|
INFN
1653
DELISTED
Infinera Corporation Common Stock
INFN
| $18.9M | 0.01% |
1,849,997
+63,641
| +4% | +$638K |
|
1654
Mativ Holdings
MATV
$706M
| $18.9M | 0.01% |
456,238
+3,618
| +0.8% | +$156K |
|
1655
Sun Life Financial
SLF
$45.8B
| $18.9M | 0.01% |
516,967
-9,157
| -2% | -$348K |
|
1656
Icon
ICLR
$12.8B
| $18.8M | 0.01% |
236,148
+3,482
| +1% | +$285K |
|
|
DCH
1657
Dauch Corp
DCH
$1.58B
| $18.8M | 0.01% |
999,794
+18,435
| +2% | +$368K |
|
|
MNR
1658
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $18.8M | 0.01% |
1,315,601
+49,384
| +4% | +$718K |
|
|
ENDP
1659
DELISTED
Endo International plc
ENDP
| $18.8M | 0.01% |
1,681,466
-416,840
| -20% | -$5.18M |
|
1660
First Solar
FSLR
$25.7B
| $18.7M | 0.01% |
691,758
-56,646
| -8% | -$1.86M |
|
1661
Compañía de Minas Buenaventura
BVN
$8.78B
| $18.7M | 0.01% |
1,554,733
+102,987
| +7% | +$1.33M |
|
1662
ORIX
IX
$43.3B
| $18.7M | 0.01% |
1,257,280
+21,160
| +2% | +$328K |
|
|
BGG
1663
DELISTED
Briggs & Stratton Corp.
BGG
| $18.7M | 0.01% |
832,125
+38,382
| +5% | +$834K |
|
1664
Enovis
ENOV
$1.4B
| $18.7M | 0.01% |
276,454
+37,913
| +16% | +$2.53M |
|
|
ALX
1665
Alexander's
ALX
$1.38B
| $18.6M | 0.01% |
43,049
+959
| +2% | +$410K |
|
|
ESPR
1666
DELISTED
Esperion Therapeutics
ESPR
| $18.5M | 0.01% |
523,610
+17,098
| +3% | +$392K |
|
1667
First Financial Corp
THFF
$962M
| $18.5M | 0.01% |
388,777
+1,667
| +0.4% | +$80K |
|
|
ALOG
1668
DELISTED
Analogic Corp
ALOG
| $18.4M | 0.01% |
242,832
+86,305
| +55% | +$6.77M |
|
1669
Alnylam Pharmaceuticals
ALNY
$29B
| $18.4M | 0.01% |
359,158
+13,199
| +4% | +$610K |
|
|
RICE
1670
DELISTED
Rice Energy Inc.
RICE
| $18.4M | 0.01% |
776,447
+40,828
| +6% | +$847K |
|
1671
Theravance Biopharma
TBPH
$876M
| $18.4M | 0.01% |
499,438
+25,884
| +5% | +$827K |
|
1672
Visteon
VC
$2.8B
| $18.4M | 0.01% |
187,654
-10,836
| -5% | -$999K |
|
|
RGC
1673
DELISTED
Regal Entertainment Group
RGC
| $18.3M | 0.01% |
811,747
-109,736
| -12% | -$2.42M |
|
|
ARI
1674
Apollo Commercial Real Estate
ARI
$871M
| $18.3M | 0.01% |
971,808
+135,638
| +16% | +$2.41M |
|
1675
Huron Consulting
HURN
$2.42B
| $18.3M | 0.01% |
434,154
+10,592
| +3% | +$467K |
|
Similar funds
Northern Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Northern Trust held 4,355 positions worth $347B, up 6.4% from $326B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q1 2017 filing shows 170 new, 2,999 increased, 961 reduced and 105 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 962,960 shares worth $52.4M. The largest sale was TotalEnergies, an estimated $2.73B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 962,960 shares worth $52.4M.
- Northern Trust added most to FlexShares Global Upstream Natural Resources Index Fund in Q1 2017, an estimated $405M increase.
- Northern Trust's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $2.73B.
- Northern Trust fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $466M.
- Northern Trust's ten largest holdings make up 14% of its $347B portfolio in Q1 2017.
- Northern Trust opened 170 new positions and closed 105 in Q1 2017.
- Northern Trust's portfolio value rose 6.4% quarter-over-quarter to $347B.
Based on Northern Trust's 13F filing for Q1 2017, filed 12 May 2017.